Treatment Considerations and the Role of BCMA-Targeting CAR T in MM

Opinion
Video

Continuing discussion centered on a patient case, the panel discusses bispecific antibody combinations and the role of BCMA-targeting CAR T-cell therapies in relapsed/refractory multiple myeloma.

Related Videos
A panel of 4 experts on multiple myeloma
A panel of 4 experts on multiple myeloma
Cesar Rodriguez, MD, and Frits van Rhee, MD, PhD
A panel of 4 experts on multiple myeloma
Cesar Rodriguez, MD, and Frits van Rhee, MD, PhD
A panel of 4 experts on multiple myeloma
4 KOLs are featured in this program.
4 KOLs are featured in this program.
A panel of 4 experts on multiple myeloma
A panel of 4 experts on multiple myeloma
Related Content